Ask AI
IMforte Safety Analysis
IMforte: Expanded Safety Analysis of Lurbinectedin + Atezolizumab vs Atezolizumab as First-line Maintenance Therapy in ES-SCLC

Released: November 13, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: November 13, 2025